These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 27003827)
1. Medication safety research by observational study design. Lao KS; Chui CS; Man KK; Lau WC; Chan EW; Wong IC Int J Clin Pharm; 2016 Jun; 38(3):676-84. PubMed ID: 27003827 [TBL] [Abstract][Full Text] [Related]
2. The limitations of observation studies for decision making regarding drugs efficacy and safety. Gueyffier F; Cucherat M Therapie; 2019 Apr; 74(2):181-185. PubMed ID: 30514576 [TBL] [Abstract][Full Text] [Related]
4. Study designs in paediatric pharmacoepidemiology. Verhamme K; Sturkenboom M Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():67-74. PubMed ID: 21107830 [TBL] [Abstract][Full Text] [Related]
5. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924 [TBL] [Abstract][Full Text] [Related]
6. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research. Targownik LE; Suissa S Am J Gastroenterol; 2015 Dec; 110(12):1647-50. PubMed ID: 26323186 [TBL] [Abstract][Full Text] [Related]
7. Counterpoint: the treatment decision design. Brookhart MA Am J Epidemiol; 2015 Nov; 182(10):840-5. PubMed ID: 26507307 [TBL] [Abstract][Full Text] [Related]
8. Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology. Noe MH; Gelfand JM J Invest Dermatol; 2018 Feb; 138(2):e13-e18. PubMed ID: 29389330 [TBL] [Abstract][Full Text] [Related]
9. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview. Uddin MJ; Groenwold RH; Ali MS; de Boer A; Roes KC; Chowdhury MA; Klungel OH Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131 [TBL] [Abstract][Full Text] [Related]
10. Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making. Caparrotta TM; Dear JW; Colhoun HM; Webb DJ Br J Clin Pharmacol; 2019 Sep; 85(9):1907-1924. PubMed ID: 31206748 [TBL] [Abstract][Full Text] [Related]
11. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Observational Studies. Snyder GM; Young H; Varman M; Milstone AM; Harris AD; Munoz-Price S Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1141-6. PubMed ID: 27322190 [TBL] [Abstract][Full Text] [Related]
12. Methodological issues in observational studies and non-randomized controlled trials in oncology in the era of big data. Tanaka S; Tanaka S; Kawakami K Jpn J Clin Oncol; 2015 Apr; 45(4):323-7. PubMed ID: 25589456 [TBL] [Abstract][Full Text] [Related]
13. Observational research--opportunities and limitations. Boyko EJ J Diabetes Complications; 2013; 27(6):642-8. PubMed ID: 24055326 [TBL] [Abstract][Full Text] [Related]
14. Use of self-controlled designs in pharmacoepidemiology. Hallas J; Pottegård A J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348 [TBL] [Abstract][Full Text] [Related]
15. Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs. Grzeskowiak LE; Gilbert AL; Morrison JL Reprod Toxicol; 2012 Jun; 33(3):280-9. PubMed ID: 22329969 [TBL] [Abstract][Full Text] [Related]
16. Cohort studies in the context of obstetric and gynecologic research: a methodologic overview. Messerlian C; Basso O Acta Obstet Gynecol Scand; 2018 Apr; 97(4):371-379. PubMed ID: 29194569 [TBL] [Abstract][Full Text] [Related]
17. Magic Mirror, On the Wall-Which Is the Right Study Design of Them All?-Part II. Vetter TR Anesth Analg; 2017 Jul; 125(1):328-332. PubMed ID: 28609341 [TBL] [Abstract][Full Text] [Related]
18. Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review. Patorno E; Garry EM; Patrick AR; Schneeweiss S; Gillet VG; Zorina O; Bartels DB; Seeger JD Drug Saf; 2015 Mar; 38(3):295-310. PubMed ID: 25761856 [TBL] [Abstract][Full Text] [Related]
19. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics. Luo X; Cappelleri JC; Frush K Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119 [TBL] [Abstract][Full Text] [Related]
20. The importance of pharmacoepidemiology in pregnancy-implications for safety. Benevent J; Montastruc F; Damase-Michel C Expert Opin Drug Saf; 2017 Oct; 16(10):1181-1190. PubMed ID: 28777918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]